Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The most common primary outcomes are sustained Alanine aminotransferase (ALT) (EC 2.6.1.2) reduction, change in liver fat on MRI-based methods, and - especially in more advanced drug trials - histologic improvement on liver biopsy.
Low compliance of children for lifestyle change necessitates other treatments
No medical treatment is approved for pediatric non- alcoholic fatty liver disease
.
see also:
[Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD) & Drugs/Treatments](brain://hxC67c…